Semaglutide App for GLP-1
By Kmish
Semaglutide App for GLP-1 is a medical tracking tool for individuals on GLP-1 and GIP peptide therapies, offering injection, protein, and lifestyle logging on iOS.
The App DNA
What makes this app unique?
The app removes the administrative friction of gathering health data for insurance prior authorization, a specific pain point for patients on expensive peptide therapies.
For Individuals prescribed GLP-1 medications like semaglutide or tirzepatide who require tracking tools for weight loss, protein intake, and insurance authorization documentation.
What does it look like?
Key features
Calculates meal plans and protein goals; premium-tier gate ($9.99/month) drives paid conversion.
Documents health changes for insurance prior authorization; premium-tier gate ($9.99/month) provides B2B-style utility.
Logs medication administration; retention loop reinforces daily usage.
How much does it cost?
The freemium model anchors on a $9.99/month subscription to gate high-utility AI features and insurance-ready documentation.
Velocity
Dormant developmentopaqueShow more...
The app has entered a zombie state, with no new feature builds or updates released in the last 151 days. Development activity is non-existent, and the last release was limited to a minor bug fix. There is no evidence of ongoing support or operational activity.
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans excited. Users appreciate the simple interface for tracking protein and water intake helps users manage their health goals effectively and integrated educational guides and books provide valuable support for users navigating their weight loss journey.
How are ratings & reviews evolving?
What users say, by theme
- The simple interface for tracking protein and water intake helps users manage their health goals effectively
- Integrated educational guides and books provide valuable support for users navigating their weight loss journey
- The free access to core tracking features allows users to manage their health without subscription costs
- Data loss and inability to view historical logs prevent users from tracking their long-term progress
38 of 38 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes and 3 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Semaglutide App for GLP-1
How's the Medical market?
Semaglutide App for GLP-1 operates in the medical category with a 4.67 rating across 851 total ratings. The lack of updates for five months signals a defensive posture rather than an aggressive pursuit of market share.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Semaglutide App for GLP-1
Where is it heading?
The GLP-1 tracking segment is consolidating around tools that offer high-accuracy clinical data, and Semaglutide App for GLP-1 is currently falling behind due to a lack of maintenance. The five-month update gap suggests the product is not a priority, which will likely accelerate churn as users seek more reliable alternatives for their insurance documentation needs.
- The five-month update gap signals a maintenance-only posture, which prevents the app from addressing critical data-loss bugs that erode user trust.
- Inaccurate barcode scanner data leads to user frustration, which compounds the churn pressure already present from technical instability.
The SWOT
- Lifestyle modification journal provides B2B-style utility for insurance prior authorization
- Protein-focused tracking addresses specific side-effect concerns like muscle mass loss
- Implement manual nutritional data override to resolve barcode scanner inaccuracies
- Add medication dosage history export to satisfy medical team documentation requests
Next best moves
Audit data persistence layer because historical log loss is a top-cited churn risk -> stabilize daily retention
+ 1 more prioritized moveThe counter-intuitive read
The app's primary value is not the tracking itself, but the insurance-ready documentation…
Read the full takeSince the last report: The app has transitioned into a maintenance-only state, with the five-month update gap now formally identified as a primary weakness and a driver of churn risk. Strategic focus has shifted toward mitigating barcode scanner inaccuracies via manual data overrides.
Bottom line
Stabilizing the data persistence layer would address the primary churn risk driving negative sentiment. If the app cannot maintain a reliable logging habit, the niche utility of the insurance documentation will not be enough to retain users against more stable competitors.
Unlock 3 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated